Total Funding
91
72
Total FundingVenture - Series Unknown raised
Growth Score
-3 pts
Heat Score
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
58138
WeHand is a biopharmaceutical company focusing on the development of hypoglycemic drugs.
Yuesheng Huang: Chairman and Founder
About the Company
WeHand is a biopharmaceutical company that focuses on innovative drugs for major diseases such as metabolic diseases, malignant tumors, anti-inflammatory immunity, and so on. WeHand focuses on strategic planning and top-level design, adheres to the concept of open cooperation and innovative development, integrates multidisciplinary and cross-field
systems, and quickly transforms original technology into products and realizes commercial value through the incubation of original innovative drugs, high-standard clinical research, and customized intelligent production lines.
